Education
About Us
Working with TipRanks
Follow Us
Progyny, Inc. (PGNY)
:PGNY
PGNY Stock Chart & Stats
$18.01
$0.60(3.43%)
At close: 4:00 PM EST
$18.01
$0.60(3.43%)
Day’s Range― - ―
52-Week Range$13.39 - $26.76
Previous CloseN/A
Volume466.97K
Average Volume (3M)1.55M
Market Cap
$1.62B
Enterprise ValueN/A
Total Cash (Recent Filing)$305.09M
Total Debt (Recent Filing)$25.50M
Price to Earnings (P/E)30.6
Beta0.73
Next Earnings
Mar 02, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding85,982,410
10 Day Avg. Volume1,143,189
30 Day Avg. Volume1,547,909
Financial Highlights & Ratios
PEG Ratio-3.15
Price to Book (P/B)3.74
Price to Sales (P/S)1.35
P/FCF Ratio9.08
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$26.50Price Target Upside47.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)0.62
Revenue Forecast (FY)$1.26B
Bulls Say, Bears Say
Bulls Say
Client GrowthManagement remains confident that it can add roughly 1 million lives to the platform in the current selling season.
Favorable UtilizationResults came in ahead of expectations and were accompanied by a guidance raise, with the company once again benefiting from favorable utilization.
Revenue GuidancePGNY increased 2025 revenue guidance, showing confidence in future growth despite macro uncertainties.
Bears Say
Competition And PricingInvestors are likely speculating on the impact of an affordable direct-to-consumer option for IVF drugs on Progyny Rx demand.
Market ReactionThe initial volatile stock reaction following the print, trading up in the after-market, then down as much as ~8%, illustrates some investor nervousness on the stock.
Progyny News
PGNY FAQ
What was Progyny, Inc.’s price range in the past 12 months?
Progyny, Inc. lowest stock price was $13.39 and its highest was $26.76 in the past 12 months.
What is Progyny, Inc.’s market cap?
Progyny, Inc.’s market cap is $1.62B.
When is Progyny, Inc.’s upcoming earnings report date?
Progyny, Inc.’s upcoming earnings report date is Mar 02, 2026 which is in 114 days.
How were Progyny, Inc.’s earnings last quarter?
Progyny, Inc. released its earnings results on Nov 06, 2025. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.127 by $0.023.
Is Progyny, Inc. overvalued?
According to Wall Street analysts Progyny, Inc.’s price is currently Undervalued.
Does Progyny, Inc. pay dividends?
Progyny, Inc. does not currently pay dividends.
What is Progyny, Inc.’s EPS estimate?
Progyny, Inc.’s EPS estimate is 0.13.
How many shares outstanding does Progyny, Inc. have?
Progyny, Inc. has 85,982,410 shares outstanding.
What happened to Progyny, Inc.’s price movement after its last earnings report?
Progyny, Inc. reported an EPS of $0.15 in its last earnings report, beating expectations of $0.127. Following the earnings report the stock price went up 24.209%.
Which hedge fund is a major shareholder of Progyny, Inc.?
Currently, no hedge funds are holding shares in PGNY
Progyny Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$26.50 (47.14% Upside)
$26.50 (47.14% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 116.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $55.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.1%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
35.32%
12-Months-Change
Fundamentals
Return on Equity
11.37%
Trailing 12-Months
Asset Growth
20.49%
Trailing 12-Months
Company Description
Progyny, Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
PGNY Company Deck
PGNY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Progyny had a strong performance this quarter with revenue and profitability exceeding expectations, a successful selling season, and a high client renewal rate. However, challenges included slightly lower than expected new covered lives and impact from a large client loss. Overall, the positive aspects significantly outweigh the negative, indicating strong business momentum.View all PGNY earnings summariesPGNY Stock 12 Month Forecast
Average Price Target
$26.50
▲(47.14% Upside)
Technical Analysis
Ownership Overview
2.07% Insiders
32.64% Mutual Funds
1.98% Other Institutional Investors
37.03% Public Companies and
Individual Investors